After finishing at $1.71 in the prior trading day, Clearside Biomedical Inc (NASDAQ: CLSD) closed at $1.56, down -8.77%. In other words, the price has decreased by -$0.1500 from its previous closing price. On the day, 856022 shares were traded.
Ratios:
Our goal is to gain a better understanding of CLSD by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.42 and its Current Ratio is at 4.42.
On July 29, 2021, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $10.
On May 13, 2020, ROTH Capital started tracking the stock assigning a Buy rating and target price of $8.ROTH Capital initiated its Buy rating on May 13, 2020, with a $8 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Feb 07 ’24 when WHITMORE BRADFORD T bought 444,444 shares for $1.35 per share. The transaction valued at 599,999 led to the insider holds 4,495,034 shares of the business.
LASEZKAY GEORGE M sold 18,000 shares of CLSD for $22,860 on Jan 19 ’24. The CEO now owns 466,577 shares after completing the transaction at $1.27 per share. On Jan 19 ’24, another insider, Deignan Charles A., who serves as the Chief Financial Officer of the company, sold 12,900 shares for $1.28 each. As a result, the insider received 16,512 and left with 384,662 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CLSD now has a Market Capitalization of 129.27M and an Enterprise Value of 101.36M. For the stock, the TTM Price-to-Sale (P/S) ratio is 14.16. Its current Enterprise Value per Revenue stands at 12.32 whereas that against EBITDA is -4.40.
Stock Price History:
Over the past 52 weeks, CLSD has reached a high of $2.12, while it has fallen to a 52-week low of $0.65. The 50-Day Moving Average of the stock is 1.4007, while the 200-Day Moving Average is calculated to be 1.1209.
Shares Statistics:
The stock has traded on average 318.68K shares per day over the past 3-months and 1.1M shares per day over the last 10 days, according to various share statistics. A total of 74.72M shares are outstanding, with a floating share count of 63.03M. Insiders hold about 15.65% of the company’s shares, while institutions hold 13.32% stake in the company. Shares short for CLSD as of Feb 29, 2024 were 275.4k with a Short Ratio of 0.86, compared to 183.92k on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 0.37% and a Short% of Float of 0.39%.
Earnings Estimates
Its stock is currently analyzed by 6 different market analysts. On average, analysts expect EPS of -$0.15 for the current quarter, with a high estimate of -$0.12 and a low estimate of -$0.2, while EPS last year was -$0.15. The consensus estimate for the next quarter is -$0.15, with high estimates of -$0.12 and low estimates of -$0.2.
Analysts are recommending an EPS of between -$0.46 and -$0.63 for the fiscal current year, implying an average EPS of -$0.53. EPS for the following year is -$0.56, with 5 analysts recommending between -$0.44 and -$0.66.
